Sign in to fuzzto save your conversations, follow your research and come back anytime.
Anthem Biosciences
SectorHealthcare
| Metric (₹ crore) | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 338.59 | 524.96 | 497.81 | 483.2 | 540.21 | 550.03 | 423.15 | 610.94 | 418.22 |
| Expenses | 217.69 | 329.73 | 338.3 | 288 | 348.72 | 332.12 | 265.95 | 343.73 | 267.65 |
| EBITDA | 120.9 | 195.23 | 159.51 | 195.2 | 191.49 | 217.91 | 157.2 | 267.21 | 150.57 |
| Depreciation | 18.68 | 19.99 | 20.28 | 30.42 | 26.45 | 33.5 | 34.53 | 39.59 | 29.99 |
| EBIT | 102.22 | 175.24 | 139.23 | 164.78 | 165.04 | 184.41 | 122.67 | 227.62 | 120.58 |
| Interest | 3.71 | 3.55 | 2.55 | 0.52 | 1.61 | 3.03 | 0.35 | 1.9 | 0.89 |
| Profit Before Tax | 98.51 | 171.69 | 136.68 | 164.26 | 163.43 | 181.38 | 122.32 | 225.72 | 119.69 |
| Net Profit | 82.38 | 161.93 | 124.33 | 82.62 | 135.79 | 173.43 | 92.82 | 189.76 | 119.94 |
| EPS | 1.47 | 2.9 | 2.22 | 1.48 | 2.43 | 3.09 | 1.65 | 3.38 | 2.13 |
| Metric (₹ crore) | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 165.52 | 277.64 | 332.91 | 305.99 | 140.15 | 270.55 | 844.49 |
| Investing Cash Flow | -109.36 | -196.03 | -205.45 | -376.02 | -221.46 | -146.98 | -701.89 |
| Financing Cash Flow | -47.63 | -63.27 | 180.68 | 63.97 | -77.18 | -135.65 | -40 |
| Net Cash Flow | 8.53 | 18.34 | 308.14 | -6.06 | -158.49 | -12.08 | 102.6 |
| Metric (₹ crore) | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 421.87 | 701.46 | 1,355 | 1,740.67 | 1,924.65 | 2,409.86 | 3,042.52 |
| Total Liabilities | 365.45 | 332.37 | 263.87 | 273.79 | 473.46 | 397.72 | 386.77 |
| Total Assets | 787.32 | 1,033.83 | 1,618.87 | 2,014.46 | 2,398.11 | 2,807.58 | 3,429.29 |